Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Reinvestment Rate
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Reinvestment Rate of 0.58x as of December 2024, reinvesting CN¥403.39 Million (capex CN¥391.52 Million plus investments CN¥11.87 Million) from operating cash flow of CN¥690.75 Million. Explore Beijing Winsunny Pharmaceutical CO.LTD capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Also explore Beijing Winsunny Pharmaceutical CO.LTD (601089) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year capital reinvestment analysis for Beijing Winsunny Pharmaceutical CO.LTD. For live market cap and broader valuation context, see 601089 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.58x | CN¥403.39 Million | CN¥690.75 Million | CN¥391.52 Million | ▼ -11.9% |
| 2023 | 0.66x | CN¥368.49 Million | CN¥555.90 Million | CN¥366.08 Million | ▲ +162.2% |
| 2022 | 0.25x | CN¥166.81 Million | CN¥659.76 Million | CN¥135.40 Million | ▼ -69.2% |
| 2021 | 0.82x | CN¥433.12 Million | CN¥528.02 Million | CN¥192.97 Million | ▼ -21.1% |
| 2020 | 1.04x | CN¥401.81 Million | CN¥386.65 Million | CN¥168.96 Million | — |